2-(2,2-diphenylcyclopropyl)-2-imidazoline,
cibenzoline,
cibenzoline succinate,
cifenline,
cifenline succinate,
cifenline, (S)-isomer,
Cipralan,
Exacor,
Cibenzoline,
Cifenline,
53267-01-9,
2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole,
Cifenline [USAN],
Cibenzolinum [INN-Latin],
Cibenzolina [INN-Spanish],
2-(2,2-diphenylcyclopropyl)-2-imidazoline,
EINECS 258-453-7,
Ro 227796,
Ro 22-7796,
UP 33901,
CHEMBL87045,
(+-)-2-(2,2-Diphenylcyclopropyl)-2-imidazoline,
C18H18N2,
Cibenzoline (INN),
Cibenzoline [INN],
Cifenline (USAN),
2-(2,2-Diphenyl-cyclopropyl)-4,5-dihydro-1H-imidazole,
Cibenzolina,
Cibenzolinum,
1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)-,
Ro-227796,
NCGC00162222-01,
up 33-901,
ACMC-20mrpi,
AC1L1EDH,
AC1Q4UEZ,
SCHEMBL122806,
DTXSID9022819,
CHEBI:135083,
BDBM50151856,
MFCD00864706,
AKOS016013956,
NCGC00162222-02,
NCGC00162222-03,
AN-40817,
CC-25773,
LS-175436,
2-(2,2-diphenyl-cyclopropyl)-2-imidazoline,
FT-0602963,
D03492,
267C019,
C-16405,
BRD-A20742938-036-01-1,
1H-Imidazole,2-(2,2-diphenylcyclopropyl)-4,5-dihydro-,
1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-,
Cipralan,
Exacor,
cibenzoline succinate,
(RS)-Cibenzoline,
(+/-)-Cibenzoline,
CIFENLINE SUCCINATE,
cifenline, (S)-isomer,
UNII-Z7489237QT,
CID2747,
AR-1L7966,
C18-H18-N2,
Z7489237QT,
C032151,
1H-Imidazole, 2-[(1R)-2,2-diphenylcyclopropyl]-4,5-dihydro-,
125836-74-0,
5414-69-7,